| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.042 | 0.3 |